
Uppsala Reports editor
@UMCGlobalSafety
When it comes to medicines, children are not just small adults. The Drug Safety Matters podcast speaks to two researchers building a resource for safer paediatric prescribing.
It’s not always easy to choose the best medicine for a child. Some drugs are inappropriate for young patients, while others require special consideration or monitoring. For years, clinicians had only historical dogmas, word of mouth, and their own experience to guide their choices. But a valuable new resource promises to change paediatric prescribing for the better.
In the latest Drug Safety Matters Long Reads episode, host Federica Santoro revisits the article “Improving medication safety for children: The KIDs List”. After the read, we speak to Rachel Meyers and David Hoff, who co-authored the KIDs List, to learn more about their work and the overall challenges of medicines safety in children.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the original article here.
Junior doctors are woefully unprepared in managing and reporting ADRs. However, a research team in the Netherlands plan to change that by rethinking pharmacovigilance education.
Education / 19 June 2023
Working together with students on their signal assessments made clear to teachers the challenges that national centres face in their pharmacovigilance work.
Education / 25 August 2023
Lack of knowledge on reporting and adverse drug reactions in general greatly impact pharmacovigilance, yet how may education be improved to tackle this?
Education / 10 May 2023